Results 21 to 30 of about 2,501,512 (375)

Topical agents: a thoughtful choice for multimodal analgesia [PDF]

open access: yesKorean Journal of Anesthesiology, 2020
For over a thousand years, various substances have been applied to the skin to treat pain. Some of these substances have active ingredients that we still use today.
Eunjoo Choi   +4 more
doaj   +1 more source

Positively Charged Lipid as Potential Tool to Influence the Fate of Ethosomes

open access: yesApplied Sciences, 2021
Ethosomes® are one of the main deformable vesicles proposed to overcome the stratum corneum. They are composed of lecithin, ethanol and water, resulting in round vesicles characterized by a narrow size distribution and a negative surface charge.
Antonia Mancuso   +4 more
doaj   +1 more source

Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model

open access: yesPharmaceutics, 2022
In the last years, microneedles (MNs) have been considered a valuable, painless, and minimally invasive approach for controlled transdermal drug delivery (TDD).
Tânia M. T. Guimarães   +8 more
doaj   +1 more source

Successful treatment of a patient with cutaneous co-infection caused by Mucor irregularis and Klebsiella pneumoniae, [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2020
The authors report a rare case of primary cutaneous mucormycosis caused by Mucor irregularis and cutaneous Klebsiella pneumoniae infections in a 67-year-old Chinese woman.
Siping Zhang, Kunju Zhu, Chi Zhang
doaj   +1 more source

Pretreatmet with 5% lidocaine patch reduces cannula-induced and propofol-induced pain: a randomized, double-blind, placebo-controlled study [PDF]

open access: yesKorean Journal of Anesthesiology, 2016
BackgroundThe purpose of this study was to determine the efficacy of 5% lidocaine patch in reducing propofol-induced pain and cannula-induced pain.MethodsIn a randomized, double-blind study, 126 patients were divided into one of three groups ...
Jung-Min Hong   +7 more
doaj   +1 more source

Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting System

open access: yesFrontiers in Oncology, 2022
Introduction Enfortumab vedotin (EV) has been demonstrated to have a significant response rate in early phase trials and is known for its tolerable side-effect profile.
Hui Yang, Xiaojia Yu, Zhuoling An
semanticscholar   +1 more source

Cutaneous blood flow during intradermal NO administration in young and older adults: roles for calcium-activated potassium channels and cyclooxygenase? [PDF]

open access: greenAmerican Journal of Physiology. Regulatory Integrative and Comparative Physiology, 2016
Nitric oxide (NO) increases cutaneous blood flow; however, the underpinning mechanism(s) remains to be elucidated. We hypothesized that the cutaneous blood flow response during intradermal administration of sodium nitroprusside (SNP, a NO donor) is ...
Naoto Fujii   +6 more
openalex   +2 more sources

Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration [PDF]

open access: yes, 2020
Background Immune checkpoint inhibitors such as nivolumab and targeted BRAF inhibitors have dramatically altered the treatment outcomes of metastatic melanoma over the past few years. Skin toxicity is the most common adverse event (AE) related to the
Maestro, Alessandra   +3 more
core   +1 more source

Transient cutaneous manifestations after administration of Pfizer‐BioNTech COVID‐19 Vaccine: an Italian single‐centre case series

open access: yesJournal of the European Academy of Dermatology and Venereology, 2021
Numerous skin manifestations associated with COVID-19 infection have been reported so far1-3 . They include vesicular or maculo-papular skin rashes, livedoid/necrotic lesions, urticaria, chilblains-like lesions and drug induced eruptions1.
M. Corbeddu   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy